Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for +publisher:"Temple University" +contributor:("Ryan, Richard R."). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Temple University

1. Inan, Saadet. Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice.

Degree: PhD, 2010, Temple University

Pharmacology

This thesis is comprised of two parts. In the first part, we investigated a) the pharmacology of GNTI, a selective kappa opioid receptor antagonist, as a scratch-inducing compound in mice and b) possible mediators and receptors that may be involved in GNTI-induced scratching (itch). We studied if GNTI induces scratching through opioid, histamine, gastrin-releasing peptide (GRP) and/or muscarinic M1 receptors. In the second part, we established similarities and differences between pain and itch using GNTI-induced scratching and formalin-induced nociception models in mice. We found that GNTI (0.03-3 mg/kg, s.c., behind the neck) induces compulsive and vigorous scratching behavior in a dose-dependent manner. A standard submaximal dose (0.3 mg/kg) of GNTI caused animals to scratch 500-600 times in a 30 min observation period. Intrathecal (i.t.) or intraperitoneal (i.p.) administration of GNTI did not elicit scratching behavior. Duration of action of GNTI was 60-70 min and tolerance to the repetitive behavior did not develop. C-fos expressing neurons, in response to GNTI injection, were localized on the lateral side of the superficial layers of the dorsal horn of the cervical spinal cord. Compound 48/80, a chemically different pruritogen, evoked c-fos expression in neurons which are located on the lateral side of the superficial layer of the dorsal horn. These data suggest that both GNTI and compound 48/80 activate a group of sensory neurons located on the lateral side of lamina I and II. Pretreating (at -20 min) and posttreating (at +5 min) mice with the kappa opioid receptor agonist, nalfurafine (0.001-0.03 mg/kg, s.c.), significantly attenuated scratching induced by GNTI (0.3 mg/kg). These effects were not a consequence of behavioral depression. Tolerance did not develop to the anti-scratch activity of nalfurafine. Pretreating mice with nalfurafine (0.02 mg/kg) prevented both GNTI- and compound 48/80-provoked c-fos expression. Our c-fos results suggest that the preclinical antipruritic activity of nalfurafine occurs at the spinal level. Moreover, our results reinforce the need to evaluate nalfurafine as a potentially useful antipruritic in human conditions involving itch. GNTI still elicited excessive scratching in mice lacking mu, delta or kappa opioid receptors, respectively, as well as in mice pretreated with either naloxone or norbinaltorphimine. The H1 receptor antagonist, fexofenadine, or the H4 receptor antagonist, JNJ 10191584, did not attenuate GNTI-induced scratching. Also, pretreating mice with the peptide GRPR antagonist, [D-Phe6]bombesin(6-13) methyl ester, or the non-peptide GRPR antagonist, RC-3095, did not antagonize scratching induced by GNTI. Furthermore, GRPR mRNA levels did not change in response to GNTI injection. Telenzepine, a standard M1 receptor antagonist, had no marked effect against GNTI-elicited scratching, however (unexpectedly) McN-A-343, an M1 receptor agonist, attenuated this behavior in a dose-dependent manner. In the second part of our studies, we found that…

Advisors/Committee Members: Cowan, Alan, Dun, Nae J., Eisenstein, Toby K., Liu-Chen, Lee-Yuan, Unterwald, Ellen M., Ashby, Barrie, Ryan, Richard R..

Subjects/Keywords: Health Sciences, Pharmacology; Neurobiology; GNTI; Itch; Kappa opioid receptor; Muscarinic receptor; Nalfurafine; Pain

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Inan, S. (2010). Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,75332

Chicago Manual of Style (16th Edition):

Inan, Saadet. “Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice.” 2010. Doctoral Dissertation, Temple University. Accessed June 06, 2020. http://digital.library.temple.edu/u?/p245801coll10,75332.

MLA Handbook (7th Edition):

Inan, Saadet. “Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice.” 2010. Web. 06 Jun 2020.

Vancouver:

Inan S. Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice. [Internet] [Doctoral dissertation]. Temple University; 2010. [cited 2020 Jun 06]. Available from: http://digital.library.temple.edu/u?/p245801coll10,75332.

Council of Science Editors:

Inan S. Pharmacological and Neuroanatomical Analysis of GNTI-Induced Repetitive Behavior in Mice. [Doctoral Dissertation]. Temple University; 2010. Available from: http://digital.library.temple.edu/u?/p245801coll10,75332

.